Navigation Links
Optimum Timing for HIV/AIDS Prognosis

A new study shows the best time to make a prognosis for someone with HIV is six months after treatment begins. Researchers find cell counts //at that time give a more accurate picture of a person’s prognosis than when they are originally diagnosed with HIV.

Highly active antiretroviral therapy (HAART) is a common treatment for HIV patients. HAART has improved the prognosis of HIV patients, however there is not a lot of information on how to predict the prognosis of each patient. Researchers in Switzerland conducted a study looking at HIV patients who had received HAART. The study analyzed the patients’ cell counts and followed how well they fared.

Results showed patients with higher CD4 counts had lower risks of AIDS or death six months after starting HAART than patients with low CD4 counts. They also found lower viral load indicated a better prognosis. However, study authors say the measurements of the CD4 cells and the viral load at the beginning of therapy was not indicative of prognosis.

Study author Matthias Egger from the University of Bern says, "At six months after starting HAART, the current CD4 cell count and viral load, but not the values before the start of therapy, are strongly associated with subsequent disease progression. Our findings should inform guidelines on when to modify HAART in this group of patients who had not previously received antiretroviral therapy."
'"/>




Page: 1

Related medicine news :

1. Salad Contains Nutrients In Optimum Level
2. Optimum Period is Five Years to Treat Osteoporosis: Study
3. Optimum Folate and Vitamin B12 Levels Essential for Cognitive Function in Seniors
4. Timing Of Womens Labor May Determine Effectiveness Of Pain Medication
5. Drink till you drop dead in English Pubs- Restriction on Timings Lifted
6. Minimally Invasive Lung Cancer Surgery Minimize the Treatment Timings
7. Timing of Food Consumption Activates Genes in Specific Brain Area
8. Study on Timing of Spinal Surgery
9. Breast Cancer Risk Influenced by the Timing of Weight Gain
10. Timing of First Intercourse is Vital
11. Timing – Crucial for Asthma Drugs to Wor
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/24/2017)... , ... May 24, 2017 , ... ... of ExtraHop to its solutions portfolio. ExtraHop delivers an analytics-first approach, layered with ... every IT system, from the datacenter to the cloud to the edge. Through ...
(Date:5/24/2017)... ... 24, 2017 , ... The CFOs included on this list ... in the nation and help their organizations navigate the challenges in healthcare today. ... in developing successful hospital and health system strategy. , Becker's Hospital Review has ...
(Date:5/23/2017)... ... May 23, 2017 , ... MDLand International (MDLand), a ... today that its iClinic V12.2 solution has achieved approval from National Center for ... PCMH 2017 standards which emphasize team-based care with a significant focus on the ...
(Date:5/23/2017)... ... May 23, 2017 , ... Cambridge, MA, May ... since 2009, according to a Workers Compensation Research Institute (WCRI) study, a contrast ... North Carolina System: CompScope™ Benchmarks, 17th Edition looks at indemnity and medical ...
(Date:5/23/2017)... ... 2017 , ... London, May 23, 2017: Walter Schindler, the Founder and Managing ... Guest Speaker and Contributor to a weeklong series of classes, meetings, field trips and ... , Walter Schindler and SAIL Capital have received an increasing number ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)...  As the specialty pharmacy industry and the ... the revolutionary shift from volume-based to value-based care, ... patient outcomes and shaping the future of the ... from clinical trials and toward data that reveals ... therapy utilization in precise patient populations. Therigy ® ...
(Date:5/18/2017)... -- Bayer announced today that the latest research from across ... 53 rd Annual Meeting of the American Society ... Chicago . The ... and thyroid cancers, as well as lymphomas, and includes ... of copanlisib in patients with relapsed or refractory follicular ...
(Date:5/15/2017)... 2017 Enterin Inc., a privately-held CNS pharmaceutical company ... compounds to treat Parkinson,s disease (PD), has enrolled the first ... 1/2a randomized, controlled, multicenter study involving patients with PD and ... patients over a 9-to-12-month period. The first stage is open ... PD. Participating sites include Denver , ...
Breaking Medicine Technology: